Literature DB >> 14677192

Do utility values and willingness to pay suitably reflect health outcome in hip and knee osteoarthritis? A comparative analysis with the WOMAC Index.

Olivier Ethgen1, Annalisa Tancredi, Eric Lejeune, Angela Kvasz, Brigitte Zegels, Jean-Yves Reginster.   

Abstract

OBJECTIVE: To establish whether health utility (time trade-off, TTO) and willingness to pay (WTP) values reflect clinical health outcome as evaluated by the Western Ontario McMaster Universities Osteoarthritis Index (WOMAC) in hip and knee osteoarthritis (OA).
METHODS: One hundred twenty-eight patients with OA attending a specialized arthritis clinic were interviewed about their socioeconomic characteristics and administered the TTO technique and the WOMAC. Their WTP for 2 hypothetical anti-osteoarthritic drugs was also investigated: the first drug was said to provide a significant improvement in WOMAC dimensions and the second a complete cure of the disease. WTP was elicited by both discrete-choice and bidding game methods. Results. Answer rates were 89.1% for TTO, 98.4% for discrete-choice WTP for both scenarios, and 89.8% and 85.2% for bidding game WTP in the relief and the cure scenario, respectively. The mean TTO utility value was 0.84 (standard deviation 0.20). In discrete-choice, those accepting the bid had higher monthly income (EURO 1536.5 vs EURO 1060.1, p < 0.001, for the relief scenario and EURO 1449.3 vs EURO 1071.6, p < 0.001, for the cure scenario). With the bidding game format, WTP was positively correlated with income in both scenarios (r = 0.56, r = 0.55, p < 0.001). WTP measures differed equally between education and socioeconomic groups with those in favored groups consistently reporting higher WTP (Kruskal-Wallis tests statistics ranging from p < 0.01 to p < 0.001). Except for stiffness, WOMAC dimensions were correlated in the expected direction with TTO values (r = -0.27, p < 0.01 for pain and r = -0.36, r = -0.34, p < 0.001 for physical function and total score, respectively).
CONCLUSION: Whereas they showed good feasibility, WTP measures poorly reflected clinical condition and were mainly related to economic status and ability to pay. TTO was correlated with the WOMAC dimensions and may be considered closer to clinical situations than WTP. However, concern arises regarding the homogeneity of the study sample in terms of clinical severity, which may have precluded the identification of a relationship between WTP and clinical status.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14677192

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  6 in total

Review 1.  A review of health-utility data for osteoarthritis: implications for clinical trial-based evaluation.

Authors:  Hirsch S Ruchlin; Ralph P Insinga
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  A comparison of directly elicited and pre-scored preference-based measures of quality of life: the case of adhesive capsulitis.

Authors:  Anthony H Harris; Joanne Youd; Rachelle Buchbinder
Journal:  Qual Life Res       Date:  2013-04-21       Impact factor: 4.147

Review 3.  The impact of economic evaluation on quality management in spine surgery.

Authors:  Norbert Boos
Journal:  Eur Spine J       Date:  2009-04-01       Impact factor: 3.134

Review 4.  Contingent Valuation Studies in Orthopaedic Surgery: A Health Economic Review.

Authors:  Benedict U Nwachukwu; Claire D Eliasberg; Kamran S Hamid; Michael C Fu; Bernard R Bach; Answorth A Allen; Todd J Albert
Journal:  HSS J       Date:  2018-04-09

5.  Assessing the Patient-Perceived Monetary Value of Patient-Reported Outcome Improvement for Patients With Chronic Knee Conditions.

Authors:  Sarah B Floyd; Alicia Oostdyk; Melanie Cozad; John M Brooks; Paul Siffri; Brian Burnikel
Journal:  J Patient Cent Res Rev       Date:  2021-04-19

6.  A community-based study of the willingness to pay associated with screening for diabetic retinopathy among type 2 diabetes in Kinmen, Taiwan.

Authors:  Hui-Chuan Shih; Pesus Chou; Shih-Jen Chen; Jorn-Hon Liu; Fenq-Li Lee; Chi-Ming Liu; Tao-Hsin Tung
Journal:  J Epidemiol       Date:  2007-11       Impact factor: 3.211

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.